Skip to main content

Gastrointestinal and Other Cancers

Conducts and supports prevention and early detection research for colorectal, esophageal, liver, pancreatic, and hematolymphoid cancers. Supports development of new approaches for clinical prevention studies, including cancer immunoprevention.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Cancer Prevention Clinical Trials Network (CP-CTNet)

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Della'Zanna, Gary, D.O., M.Sc. gary.dellazanna@nih.gov 240-276-7042	5E234	Program Officer \| Gastrointestinal and Other Cancers
	Garvey, Rodshae garveyrj@nih.gov 240-276-5764	5E220	Program Support Assistant \| Gastrointestinal and Other Cancers Program Support Assistant \| Lung and Upper Aerodigestive Cancer
	Rodriguez, Luz Maria, M.D., FACS luz.rodriguez@nih.gov 240-276-7039	5E228	Program Officer \| Gastrointestinal and Other Cancers
	Umar, Asad, D.V.M., Ph.D. asad_umar@nih.gov 240-276-7038	5E226	Chief \| Gastrointestinal and Other Cancers

Grants

PI Name	PI Organization	Title	Grant Number	Program Official
Balskus, Emily Patricia	Harvard University United States	PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	3OT2CA297577-01S1	Asad Umar, D.V.M., Ph.D.
Cao, Yin	Washington University United States	PROSPECT-Global Consortium and Risk Factor Discovery	3OT2CA297576-01S1	Asad Umar, D.V.M., Ph.D.
Spector, Tim	King'S College London United States	PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	1OT2CA297289-01	Asad Umar, D.V.M., Ph.D.
Chan, Andrew T	Massachusetts General Hospital United States	MGH- PROSPECT: Pathways, Risk factors, and mOleculeS to Prevent Early-onset Colorectal Tumors	3OT2CA297680-01S1	Asad Umar, D.V.M., Ph.D.
Chan, Andrew T	Massachusetts General Hospital United States	Precision Prevention Research Program	5R35CA253185-06	Asad Umar, D.V.M., Ph.D.
Warner, Erica T	Massachusetts General Hospital United States	Aspirins legacy on cancer and overall benefit: risk balance over a 15-year horizon	3U01CA301988-02S1	Asad Umar, D.V.M., Ph.D.
Hall, Daniel Lee	Massachusetts General Hospital United States	Innovating CBT-I for Cancer Survivors: An Optimization Trial	5R21CA279248-02
Elswick, Ronald K	Virginia Commonwealth University United States	A Randomized Controlled Trial using a Heuristic Tool To Improve Symptom Self-Management in Adolescents and Young Adults with Cancer	5R01CA286799-03	Asad Umar, D.V.M., Ph.D.
Penedo, Frank J	University Of Miami Coral Gables United States	eHealth Supported Mindfulness-based Music Therapy Intervention (eMBMT) in Hemopoietic Stem Cell Transplant Patients	4R33CA263335-03	Asad Umar, D.V.M., Ph.D.
El-Serag, Hashem B	Baylor College Of Medicine United States	Prevention of Hepatocellular Carcinoma Related to Metabolic Syndrome	5P01CA263025-04	Asad Umar, D.V.M., Ph.D.
Acciavatti, Raymond Joseph	University Of Pennsylvania United States	Next-Generation Tomosynthesis Pilot Study	5R37CA273959-04	Asad Umar, D.V.M., Ph.D.
Guo, Xingyi	Vanderbilt University Medical Center United States	Leveraging Omics and Electronic Health Records Data to study Colorectal Adenoma genetics and Drug Repurposing	1R01CA297582-01A1	Gary Della'Zanna, D.O., M.Sc.
Schmit, Stephanie L.	Cleveland Clinic Lerner Com-Cwru United States	Variation in tumor-associated immune profiles and colorectal cancer outcomes	5R01CA248931-05	Asad Umar, D.V.M., Ph.D.
Chung, Raymond T	Massachusetts General Hospital United States	Trial of Statins for Chemoprevention in Hepatocellular Carcinoma	4R01CA255621-05	Asad Umar, D.V.M., Ph.D.
Chan, Andrew T	Massachusetts General Hospital United States	Effects of inflammaging on intestinal epithelial cells and aspirin chemoprevention.	5R01CA257523-05	Asad Umar, D.V.M., Ph.D.